Recruiting

Home Dialysis & In-Center Hemodialysis

Sponsor:

Ciusss de L'Est de l'Île de Montréal

Code:

NCT06458322

Conditions

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Home dialysis or In-Center dialysis

Study Details

Brief summary:

The goal of this study is to evaluate quality of life (QoL) and frailty trajectories from advanced chronic kidney disease (CKD) to after dialysis initiation, specifically comparing patients choosing home dialysis and in-center hemodialysis.

The main questions it aims to answer are:

1. What is the trajectory of QoL in patients transitioning from advanced CKD to dialysis (up to 12 months after initiation) and how does these changes differ for patients oriented towards home dialysis and in-center hemodialysis?
2. Is the development of frailty after dialysis initiation less likely in patient pursuing home dialysis?
3. What is the variation in other PROMs and health outcomes (fatigue, anxiety \& depression, general assessment, cognitive function) form advanced CKD to the first 12 months after dialysis initiation?
4. What are the predictors of severe decline in QoL, frailty and other important health outcomes (fatigue, cognition, anxiety \& depression) during CKD G5 follow-up and after 12 months post dialysis initiation?

Participants will be ask to:

  • Answer some questions and complete questionnaires each 3 months;
  • Do a a grip test and a walking test each 6 months to evaluate their frailty;

Conditions

Chronic Kidney Diseases

Study ID

NCT06458322

Start date

Jul 1, 2022

Status verified date

Feb, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult patients followed in advanced CKD clinic;
  • eGFR ≤12 mL/min/1.73m2 96;
  • Understand English or French.

Exclusion Criteria:

  • Orientation toward conservative treatment;
  • Planned kidney transplantation < 6 months;
  • Unable to provide consent due to severe cognitive or psychiatric disease;
  • Previous treatment with dialysis > 3 month;
  • Life expectancy < 6 months.

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Home dialysis modality

Participants that determined peritoneal dialysis or home hemodialysis as their modality of treatment.

In-center dialysis modality

Participants that determined in-center hemodialysis as their modality of treatment.

Interventions

Home dialysis or In-Center dialysis

Initiation of dialysis with home dialysis (peritoneal dialysis or home hemodialysis) or in-center dialysis (hemodialysis)

Primary outcome measure

  • Change in Kidney Disease Quality of Life - 36 [ Time Frame: From study inclusion until 12-months after dialysis start. ]

Central Contacts and Locations

Central contacts

Locations

Hôpital Maisonneuve-Rosemont

Recruiting

Montreal, Quebec, Canada, H1T 2M4

Contacts

More Information

Sponsor

Ciusss de L'Est de l'Île de Montréal

Last update posted

Feb 23, 2026

Last verified

Feb, 2026

Keywords

  • Chronic Kidney Diseases
  • Quality of Life
  • Frailty
  • Dialysis
  • Home dialysis
  • In-center dialysis
  • Peritoneal dialysis
  • Home hemodialysis
  • Hemodialysis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Ciusss de L'Est de l'Île de Montréal on 2026-02-23.